A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response-Reference-Cited by-同舟云学术

A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response

Published:2024-01-01 Issue:1-2 Volume:35 Page:48-58
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Li Cong¹²^ORCID,Tian Yuying¹²,Sun Fang¹,Lei Guanglin³,Cheng Jinxia¹,Tian Chongyu¹,Yu Hongyu¹²,Deng Zhuoya¹,Lu Shuai¹,Wang Lishi²,Xiao Ruixue¹²,Bai Changqing⁴,Yang Penghui¹²

Affiliation:

1. Faculty of Hepato-Pancreato-Biliary Surgery, Institute of Hepatobiliary Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, China

2. School of Basic Medical Sciences, Inner Mongolia Medical University, Hohhot, China

3. The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China

4. Department of Respiratory, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen, China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2022.206

Reference31 articles.

1. Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma

2. Metabolic barriers to cancer immunotherapy

3. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma

4. A novel computer-aided diagnostic system for accurate detection and grading of liver tumors

5. Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer;Journal of Translational Medicine;2024-01-02